Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation

A.V. Pointon; T.M. Walker; K.M. Phillips; J.L. Luo; J. Riley; Shu-Dong Zhang; J.D. Parry; J.J. Lyon; E.L. Marczylo; T.W. Gant

doi:10.1371/journal.pone.0012733

Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation

A.V. Pointon, T.M. Walker, K.M. Phillips, J.L. Luo, J. Riley, Shu-Dong Zhang, J.D. Parry, J.J. Lyon, E.L. Marczylo, T.W. Gant

Research output: Contribution to journal › Article › peer-review

102 Citations (Scopus)

Abstract

Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity.

Original language	English
Article number	12733
Pages (from-to)	1-17
Number of pages	17
Journal	PLoS ONE
Volume	5
Issue number	9
DOIs	https://doi.org/10.1371/journal.pone.0012733
Publication status	Published - Sept 2010

ASJC Scopus subject areas

General Agricultural and Biological Sciences
General Biochemistry,Genetics and Molecular Biology
General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0012733

Cite this

Pointon, A. V., Walker, T. M., Phillips, K. M., Luo, J. L., Riley, J., Zhang, S.-D., Parry, J. D., Lyon, J. J., Marczylo, E. L., & Gant, T. W. (2010). Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation. PLoS ONE, 5(9), 1-17. Article 12733. https://doi.org/10.1371/journal.pone.0012733

@article{86e123206dc24a1db19445b9a1a9cf83,

title = "Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation",

abstract = "Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity.",

author = "A.V. Pointon and T.M. Walker and K.M. Phillips and J.L. Luo and J. Riley and Shu-Dong Zhang and J.D. Parry and J.J. Lyon and E.L. Marczylo and T.W. Gant",

year = "2010",

month = sep,

doi = "10.1371/journal.pone.0012733",

language = "English",

volume = "5",

pages = "1--17",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "9",

}

TY - JOUR

T1 - Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation

AU - Pointon, A.V.

AU - Walker, T.M.

AU - Phillips, K.M.

AU - Luo, J.L.

AU - Riley, J.

AU - Zhang, Shu-Dong

AU - Parry, J.D.

AU - Lyon, J.J.

AU - Marczylo, E.L.

AU - Gant, T.W.

PY - 2010/9

Y1 - 2010/9

N2 - Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity.

AB - Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity.

U2 - 10.1371/journal.pone.0012733

DO - 10.1371/journal.pone.0012733

M3 - Article

SN - 1932-6203

VL - 5

SP - 1

EP - 17

JO - PLoS ONE

JF - PLoS ONE

IS - 9

M1 - 12733

ER -

Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this